Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition
- Author:
Moon Kyung JOO
1
;
Chan Hyuk PARK
;
Joon Sung KIM
;
Jae Myung PARK
;
Ji Yong AHN
;
Bong Eun LEE
;
Jeong Hoon LEE
;
Hyo-Joon YANG
;
Yu Kyung CHO
;
Chang Seok BANG
;
Beom Jin KIM
;
Hye-Kyung JUNG
;
Byung-Wook KIM
;
Yong Chan LEE
;
Author Information
- Publication Type:Review
- From:Gut and Liver 2020;14(6):707-726
- CountryRepublic of Korea
- Language:English
- Abstract: Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcer were previously developed in 2009 with the collaboration of the Korean College of Helico-bacter and Upper Gastrointestinal Research and Korean So-ciety of Gastroenterology. However, the previous guidelines were based mainly upon a review of the relevant literature and expert opinion. Therefore, the guidelines need to be revised. We organized a guideline Development Commit-tee for drug-related peptic ulcer under the auspices of the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017 and developed nine statements, includ-ing four for NSAIDs, three for aspirin and other antiplatelet agents, and two for anticoagulants through a de novo process founded on evidence-based medicine that included a literature search and a meta-analysis, A consensus was reached through the application of the modified Delphi method. The primary target of these guidelines is adult pa-tients undergoing long-term treatment with NSAIDs, aspirin or other antiplatelet agents and anticoagulants. The revised guidelines reflect the expert consensus and is intended to assist clinicians in the management and prevention of druginduced peptic ulcer and associated conditions.
